Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
49
NVCR Quote, Financials, Valuation and Earnings
Last price:
$30.83
Seasonality move
:
-8.57%
Day range:
$30.33 - $31.52
52-week range:
$11.70 - $34.13
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.74x
P/B ratio:
9.25x
Volume:
1.7M
Avg. volume:
1.6M
1-year change:
138.62%
Market cap:
$3.3B
Revenue:
$509.3M
EPS (TTM):
-$1.40
NovoCure SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
NVCR
NovoCure
|
10/26/2023 | 10-Q | 10-Q filing on 10/26/2023 | View Form |
|
NVCR
NovoCure
|
07/27/2023 | 10-Q | 10-Q filing on 07/27/2023 | View Form |
|
NVCR
NovoCure
|
05/04/2023 | 10-Q | 10-Q filing on 05/04/2023 | View Form |
|
NVCR
NovoCure
|
10/27/2022 | 10-Q | 10-Q filing on 10/27/2022 | View Form |
|
NVCR
NovoCure
|
07/28/2022 | 10-Q | 10-Q filing on 07/28/2022 | View Form |
|
NVCR
NovoCure
|
04/28/2022 | 10-Q | 10-Q filing on 04/28/2022 | View Form |
|
NVCR
NovoCure
|
10/28/2021 | 10-Q | 10-Q filing on 10/28/2021 | View Form |
|
NVCR
NovoCure
|
07/29/2021 | 10-Q | 10-Q filing on 07/29/2021 | View Form |
|
NVCR
NovoCure
|
04/29/2021 | 10-Q | 10-Q filing on 04/29/2021 | View Form |
|
NVCR
NovoCure
|
10/29/2020 | 10-Q | 10-Q filing on 10/29/2020 | View Form |
|
NVCR
NovoCure
|
10/02/2020 | 10-Q | 10-Q filing on 10/02/2020 | View Form |
|
NVCR
NovoCure
|
07/30/2020 | 10-Q | 10-Q filing on 07/30/2020 | View Form |
|
NVCR
NovoCure
|
04/30/2020 | 10-Q | 10-Q filing on 04/30/2020 | View Form |
|
NVCR
NovoCure
|
02/27/2020 | 10-K | 10-K filing on 02/27/2020 | View Form |
|
NVCR
NovoCure
|
10/31/2019 | 10-Q | 10-Q filing on 10/31/2019 | View Form |
|
NVCR
NovoCure
|
07/25/2019 | 10-Q | 10-Q filing on 07/25/2019 | View Form |
|
NVCR
NovoCure
|
05/02/2019 | 10-Q | 10-Q filing on 05/02/2019 | View Form |
|
NVCR
NovoCure
|
02/28/2019 | 10-K | 10-K filing on 02/28/2019 | View Form |
|
NVCR
NovoCure
|
10/25/2018 | 10-Q | 10-Q filing on 10/25/2018 | View Form |
|
NVCR
NovoCure
|
07/26/2018 | 10-Q | 10-Q filing on 07/26/2018 | View Form |
|
NVCR
NovoCure
|
04/26/2018 | 10-Q | 10-Q filing on 04/26/2018 | View Form |
|
NVCR
NovoCure
|
02/22/2018 | 10-K | 10-K filing on 02/22/2018 | View Form |
|
NVCR
NovoCure
|
12/15/2017 | 10-Q | 10-Q filing on 12/15/2017 | View Form |
|
NVCR
NovoCure
|
12/15/2017 | 10-K | 10-K filing on 12/15/2017 | View Form |
|
NVCR
NovoCure
|
10/26/2017 | 10-Q | 10-Q filing on 10/26/2017 | View Form |
|
NVCR
NovoCure
|
07/27/2017 | 10-Q | 10-Q filing on 07/27/2017 | View Form |
|
NVCR
NovoCure
|
04/27/2017 | 10-Q | 10-Q filing on 04/27/2017 | View Form |
|
NVCR
NovoCure
|
03/01/2017 | 10-K | 10-K filing on 03/01/2017 | View Form |
|
NVCR
NovoCure
|
02/23/2017 | 10-K | 10-K filing on 02/23/2017 | View Form |
|
NVCR
NovoCure
|
11/02/2016 | 10-Q | 10-Q filing on 11/02/2016 | View Form |
|
NVCR
NovoCure
|
07/28/2016 | 10-Q | 10-Q filing on 07/28/2016 | View Form |
|
NVCR
NovoCure
|
05/10/2016 | 10-Q | 10-Q filing on 05/10/2016 | View Form |
|
NVCR
NovoCure
|
03/01/2016 | 10-K | 10-K filing on 03/01/2016 | View Form |
|
NVCR
NovoCure
|
10/27/2015 | 10-Q | 10-Q filing on 10/27/2015 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
